The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.
Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results